T Rutkowski1. 1. Department of Radiation Oncology, Maria Sklodowska-Curie Memorial Cancer Center and the Institute of Oncology, 44-101, ul. Wybrzeże Armii Krajowej 15, Gliwice, Poland, tomr22@tlen.pl.
Abstract
BACKGROUND: The aim of this study was to quantify the impact of initial tumor volume (TV) on radiotherapy (RT) outcome in patients with T2 glottic cancer. MATERIALS AND METHODS: Initial TV was calculated for 115 consecutive patients with T2 glottic cancer who had been treated with definitive RT alone at a single institution. RESULTS: The results showed strong correlations of TV with 3-year local tumor control (LTC) and disease-free survival (DFS). For TV ≤ 0.7 cm(3), 3-year LTC was 83%; for TV 0.7-3.6 cm(3) this was 70% and for TV 3.6-17 cm(3) 44%. Analysis of total dose vs. initial TV showed that larger T2 glottic tumors with a TV of around 5 cm(3) (2-2.5 cm in diameter with 10(10) cancer cells) need an extra 6.5 Gy to achieve similar 3-year LTC rates as for small tumors with a TV of 0.5 cm(3) (~1 cm in diameter with 10(9) cancer cells). CONCLUSION: Although classification of tumors according to TV cannot replace TNM staging in daily practice, it could represent a valuable numerical supplement for planning the optimal dose fractionation scheme for individual patients.
BACKGROUND: The aim of this study was to quantify the impact of initial tumor volume (TV) on radiotherapy (RT) outcome in patients with T2 glottic cancer. MATERIALS AND METHODS: Initial TV was calculated for 115 consecutive patients with T2 glottic cancer who had been treated with definitive RT alone at a single institution. RESULTS: The results showed strong correlations of TV with 3-year local tumor control (LTC) and disease-free survival (DFS). For TV ≤ 0.7 cm(3), 3-year LTC was 83%; for TV 0.7-3.6 cm(3) this was 70% and for TV 3.6-17 cm(3) 44%. Analysis of total dose vs. initial TV showed that larger T2 glottic tumors with a TV of around 5 cm(3) (2-2.5 cm in diameter with 10(10) cancer cells) need an extra 6.5 Gy to achieve similar 3-year LTC rates as for small tumors with a TV of 0.5 cm(3) (~1 cm in diameter with 10(9) cancer cells). CONCLUSION: Although classification of tumors according to TV cannot replace TNM staging in daily practice, it could represent a valuable numerical supplement for planning the optimal dose fractionation scheme for individual patients.
Authors: A A Mancuso; S K Mukherji; I Schmalfuss; W Mendenhall; J Parsons; F Pameijer; R Hermans; P Kubilis Journal: J Clin Oncol Date: 1999-02 Impact factor: 44.544
Authors: William M Mendenhall; John W Werning; Russell W Hinerman; Robert J Amdur; Douglas B Villaret Journal: Cancer Date: 2004-05-01 Impact factor: 6.860
Authors: Ralf Kurek; Anna Kalogera-Fountzila; Klaus Muskalla; Urania Dafni; Thomas Schnabel; Bernhard Kober; Sandra Röddiger; Thomas Martin; George Fountzilas; Nikolaos Zamboglou Journal: Strahlenther Onkol Date: 2003-05 Impact factor: 3.621
Authors: B O'Sullivan; W Mackillop; R Gilbert; M Gaze; J Lundgren; C Atkinson; C Wynne; H Fu Journal: Radiother Oncol Date: 1994-04 Impact factor: 6.280
Authors: Stephanie Flukes; Shivangi Lohia; Christopher A Barker; Jennifer R Cracchiolo; Ian Ganly; Snehal G Patel; Benjamin R Roman; Jatin P Shah; Alexander N Shoushtari; Viviane Tabar; Akash Shah; Marc A Cohen Journal: Head Neck Date: 2020-08-01 Impact factor: 3.147
Authors: Tomasz W Rutkowski; Bogusław Maciejewski; Zofia Kołosza; Andrzej Wygoda; Krzysztof Składowski; Beata Hejduk; Roman Rutkowski Journal: Contemp Oncol (Pozn) Date: 2014-12-31
Authors: Mohamad R Issa; Stuart E Samuels; Emily Bellile; Firas L Shalabi; Avraham Eisbruch; Gregory Wolf Journal: Cancers (Basel) Date: 2015-11-10 Impact factor: 6.639